AZTR News and Press, Azitra Inc

Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders PR Newswire BRANFORD, Conn. , March 5, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR) ("Azitra" or the "Company") , a clinical stage biopharmaceutical company focused on developing innovative th...

2026-02-27 17:37:32 ET More on Azitra Seeking Alpha’s Quant Rating on Azitra Historical earnings data for Azitra Financial information for Azitra Read the full article on Seeking Alpha For further details see: Azitra GAAP EPS of -$2.25 beat...

Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates PR Newswire BRANFORD, Conn. , Feb. 27, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precisi...

Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash PR Newswire MD Anderson Cancer Center expands ATR-04 clinical trial site footprint, offering potential to accelerate enrollment and patie...

Azitra, Inc. to Present at BIO Investment & Growth Summit Azitra, Inc. to Present at BIO Investment & Growth Summit PR Newswire BRANFORD, Conn. , Feb. 19, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on deve...

Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting PR Newswire BRANFORD, Conn. , Feb. 6, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for ...

2026-01-16 14:42:41 ET More on healthcare stocks XLV Vs. BME: Total Return Or Income, Which Healthcare Strategy Wins? IYH: Elevated Valuations And Slowing Growth Signal Subpar 2026 Returns Aldeyra Therapeutics: Reproxalap's March 2026 FDA Decision Is The Defining Cat...

Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference PR Newswire BRANFORD, Conn. , Jan. 7, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing i...

2025-12-17 16:22:25 ET More on Azitra Azitra receives notice of non-compliance from NYSE American Seeking Alpha’s Quant Rating on Azitra Historical earnings data for Azitra Financial information for Azitra Read the full article on Seeking Alp...

Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American PR Newswire BRANFORD, Conn. , Dec. 17, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapi...